TY - JOUR
T1 - Sacral neuromodulation therapy for urinary and defecatory disorders
T2 - experience in a Latin American public hospital
AU - Mass-Lindenbaum, Marcelo
AU - Arévalo-Vega, Diego
AU - Aleuanlli, Isidora
AU - Santis-Moya, Fernanda
AU - Maluenda, Andrea
AU - Dines, Eitan
AU - Cohen-Vaizer, Miriam
AU - Saavedra, Álvaro
AU - Raby, Trinidad
AU - Blumel, Bernardita
AU - Cuevas, Rodrigo
AU - Pohlhammer, Simone
AU - Alarcon, Gabriela
AU - Albornoz, Marco Arellano
AU - Pizarro-Berdichevsky, Javier
N1 - Publisher Copyright:
© 2024, Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. All rights reserved.
PY - 2024
Y1 - 2024
N2 - Objective: To show the experience of a Latin American public hospital, with SNM in the management of either OAB, NOUR or FI, reporting feasibility, short to medium-term success rates, and complications. Methods: A retrospective cohort was conducted using data collected prospectively from patients with urogynecological conditions and referred from colorectal surgery and urology services between 2015 and 2022. Results: Advanced or basic trial phases were performed on 35 patients, 33 (94%) of which were successful and opted to move on Implantable Pulse Generator (GG) implantation. The average follow-up time after definitive implantation was 82 months (SD 59). Of the 33 patients undergoing, 27 (81%)reported an improvement of 50% or more in their symptoms at last follow-up. Moreover, 30 patients (90%) with a definitive implant reported subjective improvement, with an average PGI-I “much better” and 9 of them reporting to be “excellent” on PGI-I. Conclusion: SNM is a feasible and effective treatment for pelvic floor dysfunction. Its implementation requires highly trained groups and innovative leadership. At a nation-wide level, greater diffusion of this therapy among professionals is needed to achieve timely referral of patients who require it.
AB - Objective: To show the experience of a Latin American public hospital, with SNM in the management of either OAB, NOUR or FI, reporting feasibility, short to medium-term success rates, and complications. Methods: A retrospective cohort was conducted using data collected prospectively from patients with urogynecological conditions and referred from colorectal surgery and urology services between 2015 and 2022. Results: Advanced or basic trial phases were performed on 35 patients, 33 (94%) of which were successful and opted to move on Implantable Pulse Generator (GG) implantation. The average follow-up time after definitive implantation was 82 months (SD 59). Of the 33 patients undergoing, 27 (81%)reported an improvement of 50% or more in their symptoms at last follow-up. Moreover, 30 patients (90%) with a definitive implant reported subjective improvement, with an average PGI-I “much better” and 9 of them reporting to be “excellent” on PGI-I. Conclusion: SNM is a feasible and effective treatment for pelvic floor dysfunction. Its implementation requires highly trained groups and innovative leadership. At a nation-wide level, greater diffusion of this therapy among professionals is needed to achieve timely referral of patients who require it.
KW - Electric stimulation therapy
KW - Fecal incontinence
KW - Incontinence
KW - Non-obstructive urinary retention
KW - Sacral neuromodulation
KW - Urinary bladder, overactive
UR - https://www.scopus.com/pages/publications/85193678923
U2 - 10.61622/rbgo/2024AO11
DO - 10.61622/rbgo/2024AO11
M3 - Article
C2 - 38765538
AN - SCOPUS:85193678923
SN - 0100-7203
VL - 46
JO - Revista Brasileira de Ginecologia e Obstetricia
JF - Revista Brasileira de Ginecologia e Obstetricia
M1 - e-rbgo11
ER -